Zhang, Cong C.

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

New England Journal of Medicine | July 31, 2019 | Volume: 381 | Issue: 5 | Pages: 432-443

10.1056/nejmoa1817073 | PMID 31365801